Robert Perneczky
Robert Perneczky is a prominent dementia researcher at the Alzheimer Research Center of Ludwig Maximilians University in Munich. He has been at the forefront of studying the effects of new antibody therapies on Alzheimer’s disease, emphasizing that these treatments may be most effective when administered early in the disease's progression. His insights contribute significantly to the understanding of how to combat cognitive decline associated with dementia.
Not in the pool (under ¢1).
Recent news mentions
Robert Perneczky leads a specialized department for mental illnesses in the elderly at the University Hospital of Munich.
Höheres Suizidrisiko und wichtige Warnsignale
Switzerland· 2025-07-19
Robert Perneczky is from the Alzheimer Research Center at Ludwig Maximilians University Munich.
was sie aussagen und wer sie bekommen sollteSwitzerland· 2025-02-08
Robert Perneczky from the Alzheimer Research Center at Ludwig Maximilians University in Munich discusses the effectiveness of antibodies in treating Alzheimer's disease.
Antikörper bremsen Alzheimer – können sie künftig die Demenz verhindern?Switzerland· 2025-02-08